Intra-Cellular Ther (ITCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 149,517 | 150,365 | 93,765 | 61,446 | 107,637 |
| Marketable Securities | 350,174 | 443,290 | 319,968 | 597,402 | 116,373 |
| Receivables | 114,018 | 75,189 | 20,156 | 10,765 | N/A |
| Inventories | 11,647 | 23,920 | 7,948 | 7,056 | N/A |
| TOTAL | $667,799 | $737,957 | $467,281 | $690,905 | $230,324 |
| Non-Current Assets | |||||
| PPE Net | 1,654 | 1,913 | 1,791 | 1,998 | 2,260 |
| Other Non-Current Assets | 58,842 | 14,910 | 20,850 | 24,411 | 18,603 |
| TOTAL | $60,496 | $16,823 | $22,641 | $26,409 | $20,863 |
| Total Assets | $728,295 | $754,780 | $489,922 | $717,314 | $251,187 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 11,452 | 10,395 | 8,691 | 5,502 | 7,425 |
| Accrued Expenses | 55,308 | 42,653 | 31,970 | 22,804 | 25,612 |
| TOTAL | $123,545 | $83,236 | $53,357 | $36,853 | $36,224 |
| Non-Current Liabilities | |||||
| aiOther Non-Current Liabilities | 13,326 | 15,474 | 18,675 | 23,600 | 19,955 |
| TOTAL | $13,326 | $15,474 | $18,675 | $23,600 | $19,955 |
| Total Liabilities | $136,871 | $98,710 | $72,032 | $60,454 | $56,179 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 96,807 | 95,280 | 93,594 | 80,917 | 66,133 |
| Common Shares | 10 | 9 | 8 | 8 | 6 |
| Retained earnings | -1,617,160 | -1,477,486 | -1,221,230 | -937,104 | -710,098 |
| Other shareholders' equity | 104 | -4,190 | -364 | 481 | 128 |
| TOTAL | $591,424 | $656,070 | $417,890 | $656,860 | $195,007 |
| Total Liabilities And Equity | $728,295 | $754,780 | $489,922 | $717,314 | $251,187 |